About Our Clinic

Alzheimer's disease (AD) is the most common type of dementia, making up approximately 70% of all cases. Those over the age of 65 are at a higher risk to develop AD. It diminishes cognitive, verbal and physical abilities by destroying brain cells. This in turn affects our ability to think, to learn new things, and to remember. Many scientific experts are working to ameliorate our understanding of this devastating disease, thus searching to find more effective treatments.

Our clinics partner with pharmaceutical companies to conduct Phase II and III clinical trials for Alzheimer's Disease. Our unique contribution will revolutionize the fight against the disease. We provide care to patients, generate knowledge for the scientific community, continue to improve support, and access to clinical research.

Summary

Under the authority of the Director of Clinical Research Operations, the incumbent is responsible for the imp...